DK EN

HOME ABOUT US Our company Management Our history Chiesi globally Compliance Our partnerships B Corp Annual & Sustainability Report THERAPEUTIC AREAS Respiratory Neonatology Rare diseases Special care RESEARCH & DEVELOPMENT Pipeline Production plants CONTACT WORK AT CHIESI Our Commitment Developing our People Join our team Meet Our People PHARMACOVIGILANCE Sustainability Sustainability at Chiesi How Chiesi work with sustainability Shared value Community Sustainability Plan Annual & Sustainability Report 2022 Summary of Nordic Sustainability actions 2020 SpeakUp&BeHeard MEDIA

Enter at least 3 characters

HOME
|
Management
|
CONTACT
|
PHARMACOVIGILANCE
|

Chiesi Group
DK
EN

Welcome to Chiesi

DANMARK

Enter at least 3 characters

MENU

ABOUT US
THERAPEUTIC AREAS
RESEARCH & DEVELOPMENT
- Pipeline
- Production plants
WORK AT CHIESI
Sustainability
MEDIA

HOME > Fabrys sygdom

Fabrys sygdom

-

© 2024 Chiesi Pharma AB

Klara Norra kyrkogata 34, 111 22 Stockholm
Telefon +46 8 753 35 20
E-post infonordic@chiesi.com

Sitemap
COOKIES

CREDITS
Privacy policy
SpeakUp&BeHeard

CHIESI ON THE WEB

CHIESI ON THE WEB

Austria

Chiesi Pharmaceuticals GmbH

Belgium

Chiesi sa

Brazil

Chiesi Farmacêutica Ltda

Bulgaria

Chiesi Bulgaria Ltd.

China

Chiesi Pharmaceutical (Shanghai) Co., Ltd

Czech Republic

Chiesi CZ s.r.o.

Germany

Chiesi GmbH

Greece

Chiesi Hellas Pharmaceuticals S.A.

Hungary

Chiesi Hungary Kft.

Italy

Divisione Farmaceutica Italia

Mexico

Chiesi Mexico S.A. de C.V.

Pakistan

Chiesi Pharmaceuticals (Pvt) Limited

Poland

Chiesi Polonia

Romania

Chiesi România S.r.l.

Russian Federation

Chiesi Pharmaceuticals LLC

Scandinavia

Chiesi Pharma AB

Slovak Republic

Chiesi Slovakia s.r.o

Slovenia

Chiesi Slovenija, d.o.o

Spain

Chiesi España S.A.

The Netherlands

Chiesi Pharmaceuticals B.V.

Turkey

Chiesi İlaçTicaret Limited Sirketi A.Ş.

United Kingdom

Chiesi Ltd

United States

Chiesi Usa Inc.